Study characteristics
| Variable | QALY | DALY | ||
| All | Primary geography=China | All | Primary geography=China | |
| Studies, n | 125 | 121 | 45 | 23 |
| Top three disease areas, name (%) | ||||
| 1 | Oncology (34.7) | Oncology (35.7) | Infectious and parasitic diseases (62.2) | Infectious and parasitic diseases (60.9) |
| 2 | Infectious and parasitic diseases (25.7) | Infectious and parasitic diseases (25.5) | Endocrine, nutritional and metabolic diseases (11.1) | Endocrine, nutritional and metabolic diseases (13.0) |
| 3 | Endocrine, nutritional and metabolic diseases (14.9) | Endocrine, nutritional and metabolic diseases (15.3) | Oncology (6.7) | Oncology (8.7) |
| First author affiliation=China, % | 80.8 | 82.6 | 35.6 | 65.2 |
| Academic author, % | 79.2 | 79.3 | 82.2 | 58.3 |
| Government sponsorship, % | 42.4 | 42.1 | 51.1 | 41.7 |
| Healthcare payer perspective, % | 57.1 | 58.4 | 35.6 | 26.1 |
| Quality score, mean | 5.04 | 5.05 | 4.70 | 4.41 |
Disease area categories are based on International Classification of Diseases 10th Revision (ICD-10) chapters.
DALY, disability-adjusted life-year; QALY, quality-adjusted life-year.